PT290 – Kylea Taylor, M.S., LMFT – Vital Psychedelic Conversations

Religious Practice Under Oregon Measure 109

Silo Pharma Extends Exclusive Option Agreement for Homing Peptides

Looking Ahead to a Psychedelic 2022

Entheon Biomedical Announces the Approval of DMT Clinical Trial

MINDCURE Hires Dr. Clare Purvis from Headspace to the position of...

Psyched Wellness Announces Additional Positive Results from the 14-day Oral Toxicity...

Mindset Pharma Aims to Treat Broader Addressable Neurology Market by Studying...

Mydecine Welcomes Dr. Victoria Hale as Newest Independent Board Member

Small Pharma Reports Fiscal Third Quarter 2021 Highlights

Load more